Introduction
R��������� �r��r���� (RA) �� � k��� �� �������c ���������� �������, ���c� �� ����l� c��r�c��r�z�� �� ��l��pl� j���� ���������. D�� �� ��� c������� �c���� �� ����r������ ��� ������c ��c��r�, ��� p����������� �� ��� ������� �� ��c����� ��r� c��pl�x. D��� ���� ����� ���� ��� pr���l��c� �� RA �� C���� �� �ppr�x�����l� 0.38%, ��� ���� �� E�r�p��� ��� A��r�c�� c����r��� c�� r��c� ���rl� 2.0% (1) . S��c� ��� ���� ��p�r���� c��pl�c����� �� RA �� ������l���, ���c� severely influences the patient's quality of life and causes �r��� �c�����c pr����r� �� ��c����, RA ��� ���r�c��� ��� attention of scientific researchers over the last decade (2) . T�� p����l���c�l c��r�c��r����c� �� RA ��cl��� ����r��l hyperplasia of synovial tissues, aggregation of infiltrating inflammatory cells and pannus in the synovial membrane ���c� ���� ����l��� c�r��l��� ��� l���r-l���r ����, l������ �� j���� ����r���� c������� ���� ���c���� l���.
It has been shown that the aggregation of infiltrating inflam����r� c�ll� ��� ��c��p�������� �� �������l c�ll ��p�rpl���� �r� cl���l� r�l���� �� ��� p����l��� �� RA (3) . T�� ��c������ ����l��� �� ���� ��� ���r������� �� ��l��pl� ���l������r� c�ll� �� ��� �������l ������ c�� ����c� ��� pr�l���r����� ��� ���ck����� �� �������l c�ll�, ���c� �� ����l��� �� ��� ��j�r� �� c�r��l��� ��� l���r-l���r ����. C�rr���l�, ��� cl���c�l ����-c����� ��r RA �r������� ����l� c������� �� �) ���-���r����l anti-inflammatory drugs which can relieve the acute symp-���� ��� ���� �r��� ���� ����c�� �� ��� ����r����������l �r�c�; ��) ����-���l������r� ��� ��������ppr������ �r��� ���� strong efficacy, which can fundamentally treat the disease but ���� ��� ���r�c����� �� �pp�r��� ����r�� r��c�����; ���� ��� ����c����� ��r����� ����l� ��� �� ��� l��� ��� ���) ���l���c�l medicine, including specific receptor antagonist and monoclonal antibody, which has obvious specificity and targeting. H�����r, ���l���c�l ����c��� c�� �� ���r���� r�p��l� ��� ���� ��������c��� �� ��� ����, �� ���� ��� l���-��r� ���c���� �r� ��� ����l. T��r���r�, �� �� cr�c��l �� �xpl�r� ��� c��pl�c���� mechanism of RA and seek new efficient drugs (4). 
Measurement of contents of TNF-α, IL-6 and PGE2 via
ELISA. T�� c������� �� TNF-α, IL-6 ��� PGE2 �� ��� ��r�� �� ��c� �r��p �� r��� ��r� ����c��� ����� ELISA. Exp�r������ were performed in strict accordance with the manufacturer's pr���c�l. D�r��� ��� �xp�r������, ��c� ���pl� ��� ����c��� 3 �����, ��� ��� �p�r����� pr�c����� ��r� r�p����� ���c�.
Detection of messenger RNA (mRNA) expression levels of TNF-α, IL-6 and PGE2 via RT-PCR.
T�� �������l ������ �� the rat's joint in each group was taken to extract total RNA. V���l� ����l RNA ��� ��l�c��� �� ��� ���pl��� ��r ��������� �� c��pl������r� DNA (cDNA) ��� r���r�� �r���cr�p����. Detailed PCR reaction conditions are: incubation at 42˚C for 15 min and incubation at 95˚C for 3 min, followed by cooling on ice. The samples were then frozen in the refrigerator at -80˚C for use in subsequent experiments. Routine amplification was c����c��� �cc�r���� �� ��� pr���r ��q���c�� ����� �� T��l� I.
Observation of synovial tissue pathology via H&E staining.
A� ��� ��� �� �r�� ��������r����� �� ��� S�l�����l�c Ac��-CIA group, the rats were sacrificed after the blood was collected �r�� ��� �r���. T�� �������l ������ �� ��� ��� �� �����l j���� ��� taken out and fixed in neutral formalin with a volume fraction �� 4% ��r 48 �, ��ll���� �� ���r�����, �l�c��� ��� �������� �� �cc�r���c� ���� ��� H&E �������� pr�c���r��. H&E �������� r���l�� �� ��� r�� �������l ������� �� ��c� �r��p ��r� ����r��� ����r �� �r����r� l���� ��cr��c�p� (Ol��p��, T�k��, J�p��). swelling degree in the rats' left feet between the CIA model �r��p �� ��ll �� ��� S�l�����l�c Ac��-CIA ��� c���r�l �r��p� (P<0.01), ����c����� ���� ��� ����l� ��r� �����l����� ��cc���-P<0.01), ����c����� ���� ��� ����l� ��r� �����l����� ��cc���-0.01), ����c����� ���� ��� ����l� ��r� �����l����� ��cc���-��ll�. S�l�����l�c �c�� ��� ����� �� 21 ���� ����r ��� ����l �����l�������. T�� l��� ���� j���� ���ll��� ���r��� �� ��� r��� �� ��� ��r��l c���r�l, CIA ����l ��� S�l�����l�c Ac��-CIA �r��p� ��r� ����c��� �� 21 ���� ����r �r�� ��������r�����. T�� results showed that there was significant difference between ��� S�l�����l�c Ac��-CIA �r��p ��� CIA ����l �r��p (P<0.01) (T��l� II).
Effect of salvianolic acid on serum TNF-α, IL-6 and PGE2 of CIA rats. A� ����� �� F��. 1, ��� c������� �� TNF-α, IL-6 ��� PGE2 in the serum in the CIA model group were significantly ��cr����� c��p�r�� ���� ����� �� ��� c���r�l �r��p (P<0.01). C������� �� ��r�� TNF-α, IL-6 ��� PGE2 �� ��� S�l�����l�c Ac��-CIA �r��p ��r� �������l� l���r ���� ����� �� ��� ����l �r��p (P<0.01).
Effect of salvianolic acid on mRNA expression levels of TNF-α, IL-6 and PGE2 in the synovial membrane of CIA rats.
T��l� II. C��p�r���� �� j���� ���ll��� ���r��� �� ��� l��� p����r��r ���� �� ��r�� �r��p� �� r��� (�=10). Effect of salvianolic acid on pathology of joint synovial membrane of CIA rats. A� ����� �� F��. 3, ��� H&E �������� r���l�� ������ ���� ��� �������l ������� �� ��� ��r��l c���r�l group were arranged neatly, without hyperemia and infiltration of inflammatory cells. However, the synovial tissues in the CIA model group were arranged irregularly, with infiltrating inflammatory cells. The hyperemia and infiltration of inflam����r� c�ll� �� ��� �������l ������� �� ��� S�l�����l�c Ac��-CIA group were improved significantly.
Swelling degree of the Swelling degree of the rats' left posterior l��� p����r��r ���� �� ���� ����r �r�� ��������r�����/�l 21 ���� ����r ����l ----------------------------------------------------------------------------------------------------------

Discussion
RA �� � ��p� �� ���������� �������, ����� ��j�r c��r�c-teristic is chronic inflammation in the joint synovial tissue, ��� ��� ���� p����l���c�l �������������� �r� p����l���c�l ��p�rpl���� �� �������l c�ll� ����c����� ���� ���r������� �� ����l�r����� ���l������r� c�ll�, �� ���c� ��� c�r��l��� ��� ��� l���r-l���r ���� c���r�� �� ��� �������l ����r��� �r� involved (8); therefore, the patients' quality of life and even life �r� �r���l� ��r�������. Inflammatory factors play vital roles in the occurrence and pr��r������ �� RA (9) . M���l� ��cr���� �� ��� ��cr�p�����, TNF-α is a crucial inflammatory factor for the inflammation �� �������l �������. I� �� �l�� � �����r ����c� ��r ��� �c����-tion of inflammatory cascades in the body during the network r���l����� �� ��� �cc�rr��c� �� RA, ���c�, ��� ��l� �r����r� ��� ������cl��r ��cr�p���� �� ����r��� IL-l, IL-6 ��� ����r inflammatory factors (10, 11) , but also causes a high expression �� c����k���� �� ��� ���c�l�r �������l��l c�ll�, ���� l������ to the aggregation of inflammatory cells in the inflammatory sites of synovial tissues (12) . The inflammatory factor IL-6 has complex functions and diversified targets, which can induce ��� ��r������ �� p����� ��� ���� r���rp���� �� ��� pr��r������ of inflammation of the joints. In osteoporosis, IL-6 can also promote inflammation, stimulate high expression of acute phase pr������, ����c� ������ ����r ��� ��r������ �� ������l������, c���� l�������� �� ��� ��p����l���c-p������r�-��r���l (HPA) axis regulatory mechanisms and finally lead to osteoporosis.
I� RA, ��� ��c������ �� �c���� �� IL-6 �� ���� �� ��r�������� ��� �c�������� �� IL-1 ��� TNF-α ��� ����c�� ��� ���� �xpr��-���� l���l� �� r��������� ��c��r (RF) ��� �c��� p���� pr����� �� ��� l���r. T��r���r�, IL-6 �� cr�c��l �� ��� �cc�rr��c� ��� ����l�p���� �� RA (13) . A� � r���l�, ���������� ��� �c������ ��� �xpr������ �� IL-6 �� ��� k�� �� �r������ RA. T�� �c������ and expression of PGE2, which is an important inflammatory �������r, pl�� ����l r�l�� �� RA. C�ll�������, PGE2 ��� ����r inflammatory mediators can be synthesized and secreted by synovial fibroblasts under the stimulation of TNF-α. H�����r, ��� ���� �xpr������ �� PGE2 c�� ������ ��� c�r��l��� ��� its substratum (14, 15) . Some studies have confirmed that the �cc�rr��c� ��� pr��r������ �� RA �� �cc��p����� �� ��� ���� expression of PGE2 in the serum and partial inflammatory j���� c�����, c������ �����r��� ���r��� �� �����, p��� ��� other inflammatory reactions (8, 16) . Moreover, previous find-���� ���� ����c���� ���� ������r PGE2 �� ����l� �xpr����� �� c�rr�l���� ���� ��� �x���� �� ������ �� ��� �r��c�l�r c�r��l��� ��� ��� �����r����. T��r���r�, PGE2 pl��� � pr������� r�l� �� �����l����� ������ �� �r��c�l�r c�r��l��� (17) .
I� ���� �����, ��� CIA r��� ��r� ��k�� �� ��� ����l �� �����-tigate the inhibitory effect of salvianolic acid on inflammatory �������r� �� r��� ���� c�ll����-����c�� RA. D�r��� ��� �xp�r�-�����, ��� ��kl� j���� ���ll��� �� r��� �� ��� ����l �r��p ��� �������. A���r 3 ���k� �� �r�� ��������r�����, ��� ��kl� j���� ���ll��� ���r�� �� r��� �� ��� S�l�����l�c Ac��-CIA �r��p ��� �ll������� c��p�r�� ���� ���� �� ��� ����l �r��p. T�� ELISA r���l�� ������ ���� ��� c������� �� ��r�� TNF-α, IL-6 ��� PGE2 �� ��� S�l�����l�c Ac��-CIA �r��p ��r� �������l� l���r ���� ����� �� ��� ����l �r��p. T�� RT-qPCR ����c���� r���l�� ����c���� ���� ��� �RNA �xpr������ l���l� �� TNF-α, IL-6 ��� PGE2 �� ��� S�l�����l�c Ac��-CIA �r��p ��r� ��rk��l� l���r ���� ����� �� ��� ����l �r��p. T�� H&E p����l���c�l ��c����� ������ ���� ��� ��p�r���� �� r�� �������l ������� �� ��� S�l�����l�c Ac��-CIA �r��p ��� �������l� r�l����� c��p�r�� with that in the CIA model group, and the infiltration of inflam����r� c�ll� ��� ��cr�����. I� ����l�r �������, �� ��� ����� that mangiferin can ameliorate rats' inflammations of the joints in the CIA model group, and the inflammations can be allevi-���� �� ��cr������ ��� �xpr������ l���l� �� TNF-α, IL-6, PGE2 and other inflammatory factors in the articular tissues (18) . Kamebaaurin can lower the levels of nuclear factor kappa-lightc����-�����c�r �� �c������� B c�ll� (NF-κB), TNF-α, PGE2 and other inflammatory factors in a dose-dependent manner to ��pr��� ��� ������ �� r�� �r��r���� (19) . I� c��cl�����, ��� ����l� �� CIA r��� �r� ��cc�����ll� r�pl�c����. M�r����r, ��l�����l�c �c�� ��� �� ��������r� ����c� on the RA of CIA model rats and can significantly inhibit the expression levels of relevant inflammatory mediators, such as TNF-α, IL-6 ��� PGE2.
